NCT02016235View on ClinicalTrials.gov

Role Of Phosphorus And FGF 23 In Patients With Dent Disease

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions

Dent Disease

Interventions

DRUG

Phosphorus Supplement

250 mg po qid

OTHER

Observation

Baseline blood and urine measurements only

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER